Cargando…

Novel and Controversial Therapies in COVID-19

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19) pandemic, which has led scientists all over the world to push for the identification of novel therapies for COVID-19. The lack of a vaccine and specific treatment has led to a surge...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Romil, Shaik, Likhita, Mehra, Ishita, Kashyap, Rahul, Surani, Salim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931150/
https://www.ncbi.nlm.nih.gov/pubmed/33717367
http://dx.doi.org/10.2174/1874306402014010079
_version_ 1783660234703634432
author Singh, Romil
Shaik, Likhita
Mehra, Ishita
Kashyap, Rahul
Surani, Salim
author_facet Singh, Romil
Shaik, Likhita
Mehra, Ishita
Kashyap, Rahul
Surani, Salim
author_sort Singh, Romil
collection PubMed
description The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19) pandemic, which has led scientists all over the world to push for the identification of novel therapies for COVID-19. The lack of a vaccine and specific treatment has led to a surge of novel therapies and their publicity in recent times. Under these unprecedented circumstances, a myriad of drugs used for other diseases is being evaluated and repositioned to treat COVID-19 (example- Remdesivir, Baricitinib). While multiple trials for potential drugs and vaccines are ongoing, and there are many unproven remedies with little or no supporting evidence. Presently, discussions are revolving around the use of multivitamins (Vitamin, C, D, A), minerals (selenium, zinc), probiotics, flavonoids, polyphenols, and herbal remedies (curcumin, artemisinin, herbal drinks). Our review delves further into the details of some of these controversial therapies for COVID-19.
format Online
Article
Text
id pubmed-7931150
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-79311502021-03-12 Novel and Controversial Therapies in COVID-19 Singh, Romil Shaik, Likhita Mehra, Ishita Kashyap, Rahul Surani, Salim Open Respir Med J Article The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease (COVID-19) pandemic, which has led scientists all over the world to push for the identification of novel therapies for COVID-19. The lack of a vaccine and specific treatment has led to a surge of novel therapies and their publicity in recent times. Under these unprecedented circumstances, a myriad of drugs used for other diseases is being evaluated and repositioned to treat COVID-19 (example- Remdesivir, Baricitinib). While multiple trials for potential drugs and vaccines are ongoing, and there are many unproven remedies with little or no supporting evidence. Presently, discussions are revolving around the use of multivitamins (Vitamin, C, D, A), minerals (selenium, zinc), probiotics, flavonoids, polyphenols, and herbal remedies (curcumin, artemisinin, herbal drinks). Our review delves further into the details of some of these controversial therapies for COVID-19. Bentham Science Publishers 2020-12-31 /pmc/articles/PMC7931150/ /pubmed/33717367 http://dx.doi.org/10.2174/1874306402014010079 Text en © 2020 Singh et al. https://creativecommons.org/licenses/by/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Singh, Romil
Shaik, Likhita
Mehra, Ishita
Kashyap, Rahul
Surani, Salim
Novel and Controversial Therapies in COVID-19
title Novel and Controversial Therapies in COVID-19
title_full Novel and Controversial Therapies in COVID-19
title_fullStr Novel and Controversial Therapies in COVID-19
title_full_unstemmed Novel and Controversial Therapies in COVID-19
title_short Novel and Controversial Therapies in COVID-19
title_sort novel and controversial therapies in covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931150/
https://www.ncbi.nlm.nih.gov/pubmed/33717367
http://dx.doi.org/10.2174/1874306402014010079
work_keys_str_mv AT singhromil novelandcontroversialtherapiesincovid19
AT shaiklikhita novelandcontroversialtherapiesincovid19
AT mehraishita novelandcontroversialtherapiesincovid19
AT kashyaprahul novelandcontroversialtherapiesincovid19
AT suranisalim novelandcontroversialtherapiesincovid19